Renal Mass Registry

Condition: Renal Cell Carcinoma


  • Other: questionnaire

Purpose: Collect valuable risk factor and quality of life data from Renal Cell Carcinoma patients and harness the latest technology to organize and analyze data.

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT01887574

Sponsor: Mayo Clinic

Primary Outcome Measures:

  • Measure: Evidence of Renal Mass Risk Factors as determined by patient questionnaire post surgery
  • Time Frame: 5 years
  • Safety Issue:

Estimated Enrollment: 5000

Study Start Date: June 2013


  • Age: minimum 18 Years maximum N/A
  • Gender: All

Criteria: Inclusion: – Patients with a renal mass or a suspected metastatic lesion from a renal primary who have been treated or are going to be studied and or treated surgically at Mayo Clinic Arizona – Patients must be 18 years of age or older – Patients must be capable of and willing to sign an informed consent Exclusion: None


  • Mayo Clinic in Arizona
  • Scottsdale Arizona 85259 United States

View trial on